+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Probiotics Dietary Supplements Market By Form (Capsules, Chewables & Gummies, Powders, Tablets & Softgels, and Others), By End User (Adults, Geriatric, Children, and Infants), By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027

  • PDF Icon

    Report

  • 81 Pages
  • December 2021
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5522128

The Europe Probiotics Dietary Supplements Market is expected to witness market growth of 7.5% CAGR during the forecast period (2021-2027).

Probiotics can be considered as the living microbial food ingredients that offer many health advantages. In addition, these dietary supplements fall in the category of microorganisms, which can promote health by striking the ideal balance of bacteria in the intestines. Additionally, these ingredients act as catalysts for digestive juices and enzymes in the body and facilitate the appropriate functioning of the digestive system, and can be administered through food or in the form of supplements.

Europe has been a leading region in the overall probiotics dietary supplements market. Factors such as growing utilization of probiotics, high accessibility, and the existence of key market players are acting as growth catalysts for the regional probiotics dietary supplements market.

Additionally, probiotics are also helpful to gut microflora of human, which has fueled the adoption of probiotic dairy products like yogurt and yogurt drinks made by Yakult, Nestle, and Danone across the European region. In addition, the massive demand for functional foods in the countries like France, Spain, Germany, the UK, and Italy is expected to fuel the growth of the regional market. Hence, these factors is expected to play a major role in fuelling the growth of the regional market during the forecasting period.

The Germany market dominated the Europe Probiotics Dietary Supplements Market by Country in 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $672.3 million by 2027. The UK market is exhibit a CAGR of 6.4% during (2021 - 2027). Additionally, The France market is expected to showcase a CAGR of 8.8% during (2021 - 2027).

Based on Form, the Probiotics Dietary Supplements market is segmented into Capsules, Chewables & Gummies, Powders, Tablets & Softgels, and Others. Based on End User, the market is segmented into Adults, Geriatric, Children, and Infants. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.



The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke DSM N.V., DuPont de Nemours, Inc., Chr. Hansen holding A/S, Archer Daniels Midland Company, Probi AB, BioGaia AB, Vitakem Nutraceutical, Inc., and ProbioFerm.



Scope of the Study

Market Segments Covered in the Report:


By Form

  • Capsules
  • Chewables & Gummies
  • Powders
  • Tablets & Softgels
  • and Others

By End User

  • Adults
  • Geriatric
  • Children
  • Infants

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players

List of Companies Profiled in the Report:


  • Koninklijke DSM N.V.
  • DuPont de Nemours, Inc.
  • Chr. Hansen holding A/S
  • Archer Daniels Midland Company
  • Probi AB
  • BioGaia AB
  • Vitakem Nutraceutical, Inc.
  • ProbioFerm

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Probiotics Dietary Supplements Market, by Form
1.4.2 Europe Probiotics Dietary Supplements Market, by End User
1.4.3 Europe Probiotics Dietary Supplements Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Acquisitions and Mergers
3.2.3 Product Launches and Product Expansions
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2018, Apr - 2021, Sep) Leading Players
Chapter 4. Europe Probiotics Dietary Supplements Market by Form
4.1 Europe Capsules Market by Country
4.2 Europe Chewables & Gummies Market by Country
4.3 Europe Powders Market by Country
4.4 Europe Tablets & Softgels Market by Country
4.5 Europe Other Form Market by Country
Chapter 5. Europe Probiotics Dietary Supplements Market by End-user
5.1 Europe Adults Market by Country
5.2 Europe Geriatric Market by Country
5.3 Europe Children Market by Country
5.4 Europe Infants Market by Country
Chapter 6. Europe Probiotics Dietary Supplements Market by Country
6.1 Germany Probiotics Dietary Supplements Market
6.1.1 Germany Probiotics Dietary Supplements Market by Form
6.1.2 Germany Probiotics Dietary Supplements Market by End-user
6.2 UK Probiotics Dietary Supplements Market
6.2.1 UK Probiotics Dietary Supplements Market by Form
6.2.2 UK Probiotics Dietary Supplements Market by End-user
6.3 France Probiotics Dietary Supplements Market
6.3.1 France Probiotics Dietary Supplements Market by Form
6.3.2 France Probiotics Dietary Supplements Market by End-user
6.4 Russia Probiotics Dietary Supplements Market
6.4.1 Russia Probiotics Dietary Supplements Market by Form
6.4.2 Russia Probiotics Dietary Supplements Market by End-user
6.5 Spain Probiotics Dietary Supplements Market
6.5.1 Spain Probiotics Dietary Supplements Market by Form
6.5.2 Spain Probiotics Dietary Supplements Market by End-user
6.6 Italy Probiotics Dietary Supplements Market
6.6.1 Italy Probiotics Dietary Supplements Market by Form
6.6.2 Italy Probiotics Dietary Supplements Market by End-user
6.7 Rest of Europe Probiotics Dietary Supplements Market
6.7.1 Rest of Europe Probiotics Dietary Supplements Market by Form
6.7.2 Rest of Europe Probiotics Dietary Supplements Market by End-user
Chapter 7. Company Profiles
7.1 Koninklijke DSM N.V.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Acquisitions and Mergers:
7.1.5.2 Product Launches and Product Expansions:
7.2 DuPont de Nemours, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.2.5.2 Acquisition and Mergers:
7.2.5.3 Geographical Expansions:
7.2.5.4 Product Launches and Product Expansions:
7.3 Chr. Hansen Holding A/S
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Partnerships, Collaborations, and Agreements:
7.3.5.2 Acquisition and Mergers:
7.3.5.3 Product Launches and Product Expansions:
7.4 Archer Daniels Midland Company
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.5.2 Acquisition and Mergers:
7.4.5.3 Geographical Expansions:
7.5 Probi AB
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.5.2 Acquisition and Mergers:
7.6 BioGaia AB
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.7 Vitakem Nutraceutical, Inc.,
7.7.1 Company Overview
7.8 ProbioFerm
7.8.1 Company Overview

Companies Mentioned

  • Koninklijke DSM N.V.
  • DuPont de Nemours, Inc.
  • Chr. Hansen holding A/S
  • Archer Daniels Midland Company
  • Probi AB
  • BioGaia AB
  • Vitakem Nutraceutical, Inc.
  • ProbioFerm

Methodology

Loading
LOADING...